OP0032 – Treatment of Refractory Systemic Lupus Erythematosus with Off-the-Shelf iPSC-derived Anti-C ...
Clinical Abstract Sessions: Drop the ANCA, save that vessel!
POS0431 – Drug free remission and the risk of involvement of new joints in early rheumatoid arthriti ...
POS0763 – Screening for vertebral fractures with automated VFA DXA in patients with axial spondyloar ...
POS0535 – Risk stratification in pulmonary hypertension and factors of non-adherence to the guidelin ...
OP0092 – Using an Intensive Treat-to-Target Strategy to Improve Outcomes In Early PsA: 1 Year Resul ...
POS0582 – Risk-Stratified Cost-Utility Analysis of the TREAT EARLIER Trial: One-Year Methotrexate Tr ...
OP0047 – Estimating the impact of a training workshop on the reliability of salivary gland ultrasoun ...
POS0592 – Effectiveness of Tocilizumab vs Prednisone In Rheumatoid Arthritis Patients with Insuffici ...
POS0614 – Autoantibodies directed against the angiotensin II type 1 receptor and the endothelin-1 ty ...
POS0743 – Harnessing Tolerogenic Dendritic Cells for Antigen-Specific Immune Modulation in Rheumatoi ...
POS0118 – ASAS recommendations on reporting outcomes of core outcome set instruments in axial spondy ...